Unknown PHASE2 INTERVENTIONAL 2-arm NCT01761656

Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR (ARMYDA-IMR)

Sponsor: Central South University

Conditions Acute Non-ST-segment Elevation Myocardial Infarction Stable Angina Unstable Angina

Interventions conventional dose atorvastatin loading dose atorvastatin

Updated 5 times since 2017 Last updated: Jan 7, 2013 Started: Dec 31, 2012 Primary completion: Dec 31, 2013 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01761656, this PHASE2 trial focuses on Acute Non-ST-segment Elevation Myocardial Infarction and Stable Angina and remains ongoing. Sponsored by Central South University, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Central South University

Data source: Central South University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xiangtan, China